IntelGenx Technologies Corp (IGXT): Lecanemab, an Alzheimer’s drug from Eisa...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

IntelGenx Technologies Corp (IGXT)

Reply Private New

Keep Last Read

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	3
Posts	91
Boards Moderated	0
Alias Born	07/24/2014

Re: None

Wednesday, 09/28/2022 6:16:46 AM

Wednesday, September 28, 2022 6:16:46 AM

Lecanemab, an Alzheimer’s drug from Eisai and Biogen, slowed cognitive decline in patients with early Alzheimer’s by 27% over 18 months in a final-phase trial, the companies said yesterday. That rate of decline met the study’s targets and offers hope to the 6 million people in the US with Alzheimer’s that their dementia can be slowed down or delayed. The companies hope lecanemab will fare better commercially than their previous Alzheimer’s drug Aduhelm—which was a total flop.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent IGXT News

Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 10:25:33 PM
Form 253G2 - • Edgar (US Regulatory) • 02/20/2024 07:07:33 PM
Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 02/20/2024 05:15:08 AM
Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 10:22:23 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 09:12:29 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 09:12:09 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 08:58:47 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 08:56:54 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 08:56:39 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 08:55:01 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 08:52:41 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 08:51:32 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 08:50:21 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 08:48:53 PM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 12/11/2023 09:16:43 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 01:26:48 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/28/2023 09:18:42 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:10:11 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/16/2023 08:30:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 08:01:53 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 10/06/2023 08:00:26 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 09/07/2023 01:22:58 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/06/2023 01:00:17 AM

More IGXT News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow